These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 22739177
1. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse. Li YJ, Chen C, Zeng LY, Cao J, Xu KL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):658-63. PubMed ID: 22739177 [Abstract] [Full Text] [Related]
2. [Establishment of a high efficient human coagulation factor VIII eukaryotic expression system using lentiviral vector]. Song XG, Cao J, Zeng LY, Zhang HX, Cheng H, Wang M, Wang L, Chen C, Xu KL. Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):757-61. PubMed ID: 24103872 [Abstract] [Full Text] [Related]
3. [Expression of B domain-deleted human coagulant factor VIII gene in 293T cells mediated by lentiviral vector in vitro]. Cheng H, Xu KL, Sun HY, DU B, Zeng LY, Lu QX, He XP, Pan XY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1074-8. PubMed ID: 17956694 [Abstract] [Full Text] [Related]
4. [Establishment of a high expressing system of human coagulant factor VIII in vitro]. Cheng H, Xu KL, Sun HY, Lu QX, He XP, Pan XY. Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):166-70. PubMed ID: 19642364 [Abstract] [Full Text] [Related]
5. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction. Tiede A, Eder M, von Depka M, Battmer K, Luther S, Kiem HP, Ganser A, Scherr M. Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221 [Abstract] [Full Text] [Related]
6. [Construction of lentiviral vector carrying mouse RORγt and expression of RORγt in 293FT cells]. Chen C, Zhang HX, Zeng LY, Zhang Y, Zhang JJ, Xu KL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1600-3. PubMed ID: 21176378 [Abstract] [Full Text] [Related]
7. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice. Kikuchi J, Mimuro J, Ogata K, Tabata T, Ueda Y, Ishiwata A, Kimura K, Takano K, Madoiwa S, Mizukami H, Hanazono Y, Kume A, Hasegawa M, Ozawa K, Sakata Y. J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735 [Abstract] [Full Text] [Related]
8. [Construction of lentiviral vector for mouse CXC chemokine receptor 4 gene and its expression in eukaryotic cells]. Li M, Chen W, An XJ, Cao JH, Fan CH, Yin LY, Zhang CX, Sun HM. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):198-202. PubMed ID: 23484719 [Abstract] [Full Text] [Related]
9. Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Kootstra NA, Matsumura R, Verma IM. Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905 [Abstract] [Full Text] [Related]
10. [Construction of lentiviral vector for truncated mouse fibroblast growth factor receptor-1 gene and its expression in eukaryotic cells]. Chen W, Chen C, Zhang HX, Yan ZL, Cheng H, Zeng LY, Xu KL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):168-72. PubMed ID: 22391190 [Abstract] [Full Text] [Related]
11. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Chao H, Mao L, Bruce AT, Walsh CE. Blood; 2000 Mar 01; 95(5):1594-9. PubMed ID: 10688813 [Abstract] [Full Text] [Related]
12. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Van Damme A, Chuah MK, Dell'accio F, De Bari C, Luyten F, Collen D, VandenDriessche T. Haemophilia; 2003 Jan 01; 9(1):94-103. PubMed ID: 12558785 [Abstract] [Full Text] [Related]
13. [In vivo transfection and expression of human coagulant factor VIII cDNA in mice]. Kang WY, Wang HL, Wang H, Wang XF, Wang CZ, Fu QH, Ding QL, Wu WM, Fang Y, Wang ZY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr 01; 12(2):188-93. PubMed ID: 15157331 [Abstract] [Full Text] [Related]
14. [Effect of L-arginine on human coagulant factor VIII gene expression]. Yin J, Shi GG, Zheng QT, Zeng Y, Yao GF, Lu PW, Wang XF, Wang H. Zhonghua Xue Ye Xue Za Zhi; 2007 Mar 01; 28(3):178-83. PubMed ID: 17649711 [Abstract] [Full Text] [Related]
15. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Matsui H, Shibata M, Brown B, Labelle A, Hegadorn C, Andrews C, Hebbel RP, Galipeau J, Hough C, Lillicrap D. Stem Cells; 2007 Oct 01; 25(10):2660-9. PubMed ID: 17615271 [Abstract] [Full Text] [Related]
16. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Chuah MK, Schiedner G, Thorrez L, Brown B, Johnston M, Gillijns V, Hertel S, Van Rooijen N, Lillicrap D, Collen D, VandenDriessche T, Kochanek S. Blood; 2003 Mar 01; 101(5):1734-43. PubMed ID: 12406898 [Abstract] [Full Text] [Related]
17. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Connelly S, Smith TA, Dhir G, Gardner JM, Mehaffey MG, Zaret KS, McClelland A, Kaleko M. Hum Gene Ther; 1995 Feb 01; 6(2):185-93. PubMed ID: 7537539 [Abstract] [Full Text] [Related]
18. [Effect of CXCR4 gene overexpression mediated by lentiviral vector on the biological characteristics of mesenchymal stem cells]. Chen W, Li M, Yan ZL, Chen H, Pan B, Zeng LY, Li ZY, Xu KL. Zhonghua Xue Ye Xue Za Zhi; 2013 May 01; 34(5):440-4. PubMed ID: 23688758 [Abstract] [Full Text] [Related]